Financing Will Support Development of Tioga Medical's Transcatheter Valve Technology


April 4, 2019—Tioga Medical announced today the closing of its Series A preferred stock financing, raising $15 million. The funds will be used to advance Tioga Medical's preclinical and clinical development programs. Tioga Medical is developing a novel transcatheter valve replacement technology for mitral and tricuspid applications.

Tioga Medical is a newly formed company in the portfolio of Shifamed, LLC, which is a specialized medical innovation hub founded by Amr Salahieh. The financing was led by The Capital Partnership, with significant participation from Cormorant Healthcare Fund, AMED Ventures, and Shangbay Capital reported the company.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.